O’Connor, C. M., Gattis, W. A., Adams, K. F., Shah, M. R., Frey, A., Gheorghiade, M., & Randomized Intravenous Tezosentan Study Investigators, . (2003). Tezosentan in patients with acute heart failure and acute coronary syndromes: design of the fourth Randomized Intravenous Tezosentan Study (RITZ-4). Am Heart J, 145(2 Suppl), S58–S59. https://doi.org/10.1067/mhj.2003.156

O’Connor, Christopher M., Wendy A. Gattis, Kirkwood F. Adams, Monica R. Shah, Aline Frey, Mihai Gheorghiade, and Mihai Randomized Intravenous Tezosentan Study Investigators. “Tezosentan in patients with acute heart failure and acute coronary syndromes: design of the fourth Randomized Intravenous Tezosentan Study (RITZ-4).” Am Heart J 145, no. 2 Suppl (February 2003): S58–59. https://doi.org/10.1067/mhj.2003.156.

O’Connor CM, Gattis WA, Adams KF, Shah MR, Frey A, Gheorghiade M, et al. Tezosentan in patients with acute heart failure and acute coronary syndromes: design of the fourth Randomized Intravenous Tezosentan Study (RITZ-4). Am Heart J. 2003 Feb;145(2 Suppl):S58–9.

O’Connor, Christopher M., et al. “Tezosentan in patients with acute heart failure and acute coronary syndromes: design of the fourth Randomized Intravenous Tezosentan Study (RITZ-4).” Am Heart J, vol. 145, no. 2 Suppl, Feb. 2003, pp. S58–59. Pubmed, doi:10.1067/mhj.2003.156.

O’Connor CM, Gattis WA, Adams KF, Shah MR, Frey A, Gheorghiade M, Randomized Intravenous Tezosentan Study Investigators. Tezosentan in patients with acute heart failure and acute coronary syndromes: design of the fourth Randomized Intravenous Tezosentan Study (RITZ-4). Am Heart J. 2003 Feb;145(2 Suppl):S58–S59.